Bio-Techne and Refeyn launch integrated workflow for bispecific antibody and biosimilar characterization

news-medical.net

Bio-Techne and Refeyn have launched an integrated workflow for characterizing bispecific antibodies and biosimilars. This new method combines Bio-Techne's icIEF fractionation system with Refeyn's mass photometry platform, allowing researchers to analyze charge variants alongside molecular weight and aggregation at single-molecule resolution. The workflow aims to streamline the complex characterization process for these rapidly growing biotherapeutics, reducing development time and manufacturing risks.


With a significance score of 1.7, this news ranks in the top 32% of today's 32773 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Bio-Techne and Refeyn launch integrated workflow for bispecific antibody and biosimilar characterization | News Minimalist